New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation.
暂无分享,去创建一个
M Fini | R Giardino | M Morra | C Cassinelli | A. Nicolini | M. Morra | C. Cassinelli | A. Carpi | R. Giardino | M. Fini | G. Giavaresi | M. Tschon | G Giavaresi | M Tschon | V Borsari | J H Daly | J J Liggat | V Bonazzi | A Nicolini | A Carpi | J. Liggat | V. Borsari | V. Bonazzi | J. Daly
[1] S. Perren,et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.
[2] R. Giardino,et al. Natural and Synthetic Polyesters for Musculoskeletal Tissue Repair: Experimental in Vitro and in Vivo Evaluations , 2004, The International journal of artificial organs.
[3] D. Hayward,et al. The effect of processing on the properties of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymers , 2001 .
[4] J. Anglen,et al. Elution Characteristics of Tobramycin From Polycaprolactone in a Rabbit Model , 2001, Clinical orthopaedics and related research.
[5] T. Vail,et al. Pharmacokinetics of a Degradable Drug Delivery System in Bone , 1998, Clinical orthopaedics and related research.
[6] S. Davis,et al. The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres , 2002, Journal of Microencapsulation.
[7] A. Göpferich,et al. Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. , 2000, Biomaterials.
[8] J. Calhoun,et al. Experimental Osteomyelitis Treatment With Antibiotic-Impregnated Hydroxyapatite , 2002, Clinical orthopaedics and related research.
[9] B. Tighe,et al. Polymers for biodegradable medical devices. III. Polymerization and copolymerization of cyclic derivatives of tartronic acid. , 1987, Biomaterials.
[10] F. Korkusuz,et al. In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods , 2002, Journal of microencapsulation.
[11] John Samuel,et al. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.
[12] V. Hasırcı,et al. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release , 2001, Journal of biomaterials science. Polymer edition.
[13] V. Hasırcı,et al. Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules. , 1995, Journal of microencapsulation.
[14] F. Korkusuz,et al. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. , 2001, Biomaterials.
[15] J W Eaton,et al. Inflammatory responses to biomaterials. , 1995, American journal of clinical pathology.
[16] Terumi Saito,et al. In vivo and in vitro degradation of poly(3-hydroxybutyrate) in pat , 1991 .
[17] S. W. Kim,et al. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. , 2001, Bio-medical materials and engineering.
[18] J. Calhoun,et al. Treatment of Experimental Osteomyelitis With a Fibrin Sealant Antibiotic Implant , 2002, Clinical orthopaedics and related research.
[19] A. Albertsson,et al. Resorbable and highly elastic block copolymers from 1,5-dioxepan-2-one and L-lactide with controlled tensile properties and hydrophilicity. , 2002, Biomacromolecules.
[20] Shen‐guo Wang,et al. Biodegradable poly(L-lactide)-poly(ethylene glycol) multiblock copolymer: synthesis and evaluation of cell affinity. , 2003, Biomaterials.
[21] D. Zaffe,et al. A reabsorbable tubular chamber for the treatment of large diaphyseal bone defects. Experimental study in rabbits. , 1998, The International journal of artificial organs.
[22] D. Wise,et al. Antibiotic release from biodegradable PHBV microparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[23] Steven P Schwendeman,et al. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.
[24] Andrianov,et al. Protein release from polyphosphazene matrices. , 1998, Advanced drug delivery reviews.
[25] P. Caliceti,et al. Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[26] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[27] P. Caliceti,et al. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[28] J. Anglen,et al. Treatment of Osteomyelitis With Local Antibiotics Delivered Via Bioabsorbable Polymer , 2003, Clinical orthopaedics and related research.
[29] B. Tighe,et al. Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: hydrolytic degradation studies. , 1987, Biomaterials.
[30] N. Özer,et al. Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study , 2002, Journal of microencapsulation.
[31] F. Korkusuz,et al. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. , 1999, Journal of biomedical materials research.
[32] R. Weusthuis,et al. Properties, modifications and applications of biopolyesters. , 2001, Advances in biochemical engineering/biotechnology.
[33] M Fini,et al. Tailoring Biomaterial Compatibility: In Vivo Tissue Response versus in Vitro Cell Behavior , 2003, The International journal of artificial organs.